Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04GPZ
|
|||
| Former ID |
DIB012536
|
|||
| Drug Name |
Hyaluronidase (ovine)
|
|||
| Synonyms |
Hyaluronidase; Hydase; Vitragan; Vitrase; Hyaluronidase Injection; Hyaluronidase (vitreous hemorrhage), ISTA
Click to Show/Hide
|
|||
| Indication | Resorption of radiopaque agents [ICD-11: N.A.] | Approved | [1] | |
| Company |
PrimaPharm; Primapharm
|
|||
| ADReCS Drug ID | BADD_D01078 ; BADD_D01080 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hyaluronic acid (HA) | Target Info | Modulator | [1], [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2005 approvals: Safety first. Nature Reviews Drug Discovery 5, 92-93 (February 2006). | |||
| REF 2 | Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005 Oct;140(4):585-97. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.